firstlinetherapyforrheumatoidarthritis.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: Googlebot Disallow: /?* User-agent: Baiduspider Disallow: /?* User-agent: YandexBot Disallow: /?* User-agent: ichiro Disallow: /?* User-agent: sogou spider Disallow: /?* User-agent: Sosospider Disallow: /?* User-agent: YoudaoBot Disallow: /?* User-agent: YetiBot Disallow: /?* User-agent: bingbot Crawl-delay: 2 Disallow: /?* User-Agent: Yahoo! Slurp Crawl-delay: 2 Disallow: /?* User-agent: rdfbot Disallow: /?* User-agent: Seznambot Request-rate: 1/2s Disallow: /?* User-agent: ia_archiver Disallow: User-agent: Mediapartners-Google | ||
Meta Tags
| Title | firstlinetherapyforrheumatoidarthritis.com |
| Description | firstlinetherapyforrheumatoidarthritis.com 2022 Copyright. All Rights Reserved. Privacy |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | |
| Location |
Related Websites
| Site | Rank |
More to Explore
firstlinetherapyforrheumatoidarthritis.com Valuation
|
US$455
Last updated: 2022-10-18 11:26:35
firstlinetherapyforrheumatoidarthritis.com has Semrush global rank of 0. firstlinetherapyforrheumatoidarthritis.com has an estimated worth of US$ 455, based on its estimated Ads revenue. firstlinetherapyforrheumatoidarthritis.com receives approximately 52 unique visitors each day. Its web server is located in , with IP address . According to SiteAdvisor, firstlinetherapyforrheumatoidarthritis.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$455 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$12 |
| Yearly Ads Revenue | US$151 |
| Daily Unique Visitors | 3 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| firstlinetherapyforrheumatoidarthritis.com. 3600 IN A 185.53.177.31 | A | IP: firstlinetherapyforrheumatoidarthritis.com. 3600 IN A 185.53.177.31 | |
| firstlinetherapyforrheumatoidarthritis.com. 3600 IN NS ns2.nic53.de. | NS | NS Record: firstlinetherapyforrheumatoidarthritis.com. 3600 IN NS ns2.nic53.de. | |
| firstlinetherapyforrheumatoidarthritis.com. 3600 IN NS ns1.nic53.net. | NS | NS Record: firstlinetherapyforrheumatoidarthritis.com. 3600 IN NS ns1.nic53.net. | |
| firstlinetherapyforrheumatoidarthritis.com. 21600 IN TXT v=spf1 -all | TXT | TXT Record: firstlinetherapyforrheumatoidarthritis.com. 21600 IN TXT v=spf1 -all |
HtmlToTextCheckTime:2022-10-18 11:26:35
| firstlinetherapyforrheumatoidarthritis.com 2022 Copyright. All Rights Reserved. Privacy |
HTTP Headers
HTTP/1.1 200 OK Server: nginx Date: Sun, 20 Feb 2022 09:09:05 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Vary: Accept-Encoding X-Buckets: bucket063 X-Adblock-Key: MFwwDQYJKoZIhvcNAQEBBQADSwAwSAJBALquDFETXRn0Hr05fUP7EJT77xYnPmRbpMy4vk8KYiHnkNpednjOANJcaXDXcKQJN0nXKZJL7TciJD8AoHXK158CAwEAAQ==_YJXe/TnOSoSvP2lt1Jtb7Cy9tlyQ9OwP/lMxu3eCrBekr6QgokY/KIRplxUndMMW1RYn41hYm5nne5YOCpJS6w== X-Template: tpl_Mangfall_twoclick X-Language: finnish Accept-CH: viewport-width Accept-CH: dpr Accept-CH: device-memory Accept-CH: rtt Accept-CH: downlink Accept-CH: ect Accept-CH: ua Accept-CH: ua-full-version Accept-CH: ua-platform Accept-CH: ua-platform-version Accept-CH: ua-arch Accept-CH: ua-model Accept-CH: ua-mobile Accept-CH-Lifetime: 30 |
firstlinetherapyforrheumatoidarthritis.com Whois Information
Domain Name: FIRSTLINETHERAPYFORRHEUMATOIDARTHRITIS.COM Registry Domain ID: 2651801099_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2022-01-25T16:22:16Z Creation Date: 2021-11-01T14:45:17Z Registry Expiry Date: 2022-11-01T14:45:17Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.NIC53.NET Name Server: NS2.NIC53.DE DNSSEC: unsigned >>> Last update of whois database: 2022-02-20T10:00:46Z <<< |